Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for CYP2D6, CYP2C19, CYP2B6, SLC6A4, and HTR2A Genotypes and Serotonin …

CA Bousman, JM Stevenson… - Clinical …, 2023 - Wiley Online Library
Serotonin reuptake inhibitor antidepressants, including selective serotonin reuptake
inhibitors (SSRIs; ie, citalopram, escitalopram, fluoxetine, fluvoxamine, paroxetine, and …

How and why to screen for CYP2D6 interindividual variability in patients under pharmacological treatments

M De Gregori, M Allegri, S De Gregori… - Current drug …, 2010 - ingentaconnect.com
Cytochromes P450 are members of a superfamily of hemoproteins that catalyze a variety of
oxidative reactions in the metabolism of endogenous and exogenous hydrophobic …

Real time PCR detection of common CYP2D6 genetic variants and its application in a Karen population study

K Puaprasert, C Chu, N Saralamba, NPJ Day, F Nosten… - Malaria Journal, 2018 - Springer
Background Plasmodium vivax malaria is characterized by relapses arising from the
hypnozoite stages in the liver. The only currently registered drug for radical treatment to …

The association of CYP2D6 genotype and postoperative nausea and vomiting in orthopedic trauma patients

SW Wesmiller, RA Henker, SM Sereika… - … research for nursing, 2013 - journals.sagepub.com
The CYP2D6 gene encodes for an enzyme that is involved in the metabolism of more than
25% of all medications, including many opioids and antiemetics. It may contribute to the risk …

Impact of metabolizing enzymes on drug response of endocrine therapy in breast cancer

PH Saladores, JC Precht, W Schroth… - Expert review of …, 2013 - Taylor & Francis
Estrogen-receptor positive breast cancer accounts for 75% of diagnosed breast cancers
worldwide. There are currently two major options for adjuvant treatment: tamoxifen and …

[PDF][PDF] Genetics and antidepressants: where we are

S Porcelli, C Fabbri, A Drago, S Gibiino… - Clin …, 2011 - ecnp.eu
Nowadays antidepressants are still administrated by a trial and error principle and a
substantial proportion of patients does not benefit from treatment or suffers from significant …

Effect of CYP2D6, 2C19, and 3A4 Phenoconversion in Drug-Related Deaths

SM Aly, B Hennart, JM Gaulier, D Allorge - Toxics, 2024 - mdpi.com
Molecular autopsy is a very important tool in forensic toxicology. However, many
determinants, such as co-medication and physiological parameters, should be considered …

CYP2D6 genotyping and use of antidepressants in breast cancer patients: test development for clinical application

N Van der Merwe, CSH Bouwens, R Pienaar… - Metabolic brain …, 2012 - Springer
Approximately 25% of clinically important drugs and numerous environmental carcinogens
are metabolised by CYP2D6. Variation in the CYP2D6 gene and concomitant use of …

Is toxicity of PMMA (paramethoxymethamphetamine) associated with cytochrome P450 pharmacogenetics?

M Vevelstad, EL Øiestad, S Bremer, IL Bogen… - Forensic science …, 2016 - Elsevier
Abstract In 2010–2013, 29 fatal intoxications related to the designer drug
paramethoxymethamphetamine (PMMA, 4-methoxymethamphetamine) occurred in Norway …

Benchmarking analysis of deleterious SNP prediction tools on CYP2D6 enzyme

KCV Ferreira, LF Fialho, OL Franco… - Chemical biology & …, 2020 - Wiley Online Library
The cytochrome P450 family is composed of hemeproteins involved in the metabolic
transformation of endogenous and exogenous substances. The CYP2D6 enzyme is …